Boston Scientific Corporation
BSX | NYSE
$41.98
-$0.71 (-1.66%)
At close: Oct 30, 2026, 4:00 PM ET
$42.05
+$0.07 (+0.17%)
Pre-market:
Nov 2, 2026, 8:45 AM ET
Market Data
Market Cap $60.84B
Enterprise Value $72.92B
Beta 0.58
Average Volume 20M
Shares Outstanding (Diluted) 1.45B
Shares Change YoY -2.91%
Institutional Ownership 90.62%
Exchange NYSE
ISIN US1011371077
Price Performance
Price Change 1M -3.8%
Price Change 3M -10.2%
Price Change 6M -25.7%
Price Change YTD -56.0%
Price Change 1Y -58.3%
Price Change 3Y -18.0%
Price Change 5Y -2.7%
1M CAGR (ann.) -3.1%
1Y CAGR (ann.) -58.1%
5Y CAGR (ann.) -1.3%
All-Time CAGR 6.7%
Valuation
PE Ratio 17.79
Forward PE 13.32
PEG Ratio 0.70
Forward PEG 3.56
PS Ratio 2.89
Forward PS 2.90
PB Ratio 2.44
P/FCF Ratio 16.78
P/Adj. FCF Ratio 17.59
P/OCF Ratio 13.41
EV/Sales 3.46
EV/EBIT 16.79
EV/EBITDA 13.47
EV/FCF 20.12
Earnings Yield 5.6%
FCF Yield 6.0%
Adj. FCF Yield 5.7%
Financial Health
Net Debt $11.96B
Total Debt $12.62B
Cash & Short-Term Investments $539M
Total Assets $45.22B
Current Ratio 1.24
Quick Ratio 0.74
Debt / Equity Ratio 0.51
Debt / EBITDA 2.33
Debt / FCF 3.48
OCF / Debt 0.36
Interest Coverage 11.80
Altman Z-Score 2.89
Piotroski F-Score 8
Margins & Profitability
Gross Profit Margin 70.4%
Operating Profit Margin 21.1%
EBITDA Margin 25.7%
Net Profit Margin 16.6%
FCF Margin 17.2%
Adj. FCF Margin 16.4%
SBC / Revenue 0.8%
SBC Impact (per share) -4.6%
Returns
Return on Assets 7.7%
Return on Equity 14.2%
Return on Invested Capital 10.5%
Return on Capital Employed 11.4%
Return on Tangible Assets 17.8%
Historical Growth (CAGR)
Revenue CAGR 3Y 15.3%
Revenue CAGR 5Y 12.9%
Revenue CAGR 10Y 9.9%
EPS CAGR 3Y 42.2%
EPS CAGR 5Y 26.4%
EPS CAGR 10Y 44.4%
FCF CAGR 3Y 36.5%
FCF CAGR 5Y 15.6%
FCF CAGR 10Y 14.0%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 25
EPS Growth Next 3Y 16.3%
Revenue Growth Next 3Y 3.7%
Earnings Date Feb 3, 2027
EPS Estimate (next Q) $0.79
EPS Growth Est (next Q) -1.3%
Revenue Est (next Q) $5.2B
Revenue Growth Est (next Q) -1.7%
Fair Value Estimates
Graham Number $30.38
Graham Upside -27.6%
Lynch Fair Value $59.00
Lynch Upside 40.5%
Price Target $54.65
Price Target Upside 30.2%
Cash Flow
Operating Cash Flow $4.53B
Free Cash Flow $3.63B
Adj. Free Cash Flow $3.46B
FCF Per Share $2.50
OCF Per Share $3.13
OCF/S Ratio 21.5%
Income Statement
Revenue $21.07B
Gross Profit $14.83B
Operating Income $4.44B
EBITDA $5.41B
Net Income $3.49B
EPS (Diluted) $2.36
Revenue / Employee $357.1K
Profit / Employee $59.15K
Employees 59,000
Add to Watchlist
Select watchlists to add or remove BSX